Pluristem Therapeutics OverviewPluristem Therapeutics Net Income
Profitability analysis for PSTI.
Quarterly Net Income
-$6.17M
↑ 2.57% YoY
As of Mar 2026
Annual Net Income (TTM)
-$10.19M
↑ 59.99% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...